EP3226843
Krabbameinseyðandi samsetningar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.12.2015EP published:
26.5.2021EP application number:
15820351.3
EP translation filed:
26.7.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
2.12.2035Expiry date:
2.12.2023
Title:
ANTICANCER COMPOSITIONS
Timeline
Today
3.12.2015EP application
26.5.2021EP Publication
26.7.2021Translation submitted
15.9.2021Registration published
2.12.2023Expires
Owner
Name:
Aragon Pharmaceuticals, Inc.Address:
10990 Wilshire Blvd, Suite 440, Los Angeles, CA 90024, US
Inventor
Name:
VERRECK, GeertAddress:
2340 Beerse, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14196605Date:
5.12.2014Country:
EP
Classification
Categories:
A61K 9/20, A61P 35/00, A61P 35/04, A61K 9/14, A61K 31/4439
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 8.11.2021
Expires: 2.12.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.11.2022
Expires: 2.12.2023
Payer: Árnason Faktor ehf.